Nath, A.R.; Kumar, A.; Bhate, A.S.; Mehrotra, B.; Rai, D.K.; Barge, V.K.; Bhojwani, D.; Bhagat, S.; Bhushan, S.; Patil, S.;
et al. Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study. Adv. Respir. Med. 2025, 93, 53.
https://doi.org/10.3390/arm93060053
AMA Style
Nath AR, Kumar A, Bhate AS, Mehrotra B, Rai DK, Barge VK, Bhojwani D, Bhagat S, Bhushan S, Patil S,
et al. Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study. Advances in Respiratory Medicine. 2025; 93(6):53.
https://doi.org/10.3390/arm93060053
Chicago/Turabian Style
Nath, Anjali R., Adesh Kumar, Amit Suresh Bhate, Bharat Mehrotra, Deependra Kumar Rai, Vijay Kumar Barge, Divya Bhojwani, Sagar Bhagat, Sumit Bhushan, Saiprasad Patil,
and et al. 2025. "Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study" Advances in Respiratory Medicine 93, no. 6: 53.
https://doi.org/10.3390/arm93060053
APA Style
Nath, A. R., Kumar, A., Bhate, A. S., Mehrotra, B., Rai, D. K., Barge, V. K., Bhojwani, D., Bhagat, S., Bhushan, S., Patil, S., & Barkate, H.
(2025). Effectiveness and Safety of Glycopyrronium–Formoterol–Budesonide Triple Therapy in Chronic Obstructive Pulmonary Disease (AIR-FORCE): An Open-Label Multi-Centric Phase 4 Study. Advances in Respiratory Medicine, 93(6), 53.
https://doi.org/10.3390/arm93060053
